切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Topoisomerases - EP300 - S-nitrosoglutathione reductase - M2 Receptors

21件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  4. Gallamine Triethiodide
    B1610 Gallamine Triethiodide
    中文名: 加拉碘铵,弛肌碘,戈拉碘铵
    Target: M2 Receptors
    Summary: 胆碱能受体阻断剂
      ≥44.58 mg/mL
      ≥54.6 mg/mL
  5. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  6. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  7. N6022
    B1111 N6022
    Target: S-nitrosoglutathione reductase
    Summary: GSNOR抑制剂
      ≥20.7 mg/mL
      insoluble in H2O
  8. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  9. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  10. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL

21件产品中的 1-10

页面
每页